摘要
背景:牛血清白蛋白具有良好的生物相容性、生物降解性、表面功能化和高水溶性等优点,在纳米医学中受到越来越多的关注。奥贝耶ctive:尽管对基于白蛋白的纳米粒子进行了许多综述,但它们大多集中在白蛋白功能的一个方面,例如药物传递、癌症热疗法或半衰期延长。在体内。本文综述了牛血清白蛋白在肿瘤影像学和治疗中的应用。 方法:综述牛血清白蛋白在药物载体、表面工程和仿生合成中的广泛应用。 结论:在综述的基础上,各种体外和体内研究表明牛血清白蛋白作为药物载体、表面修饰剂和仿生模板具有良好的性能。在癌症成像和治疗中。然而,仍有一些问题有待解决,如提高载药效率和控制释药的工艺参数等。通过表面改性工艺提供更稳定的纳米制剂,研究其仿生机理,深入研究其毒性,进一步探索其生物应用等。
关键词: 纳米无机物,BSA,药物载体,表面修饰,生物模拟纳米粒子,癌症成像和治疗。
Current Medicinal Chemistry
Title:Bovine Serum Albumin as a Versatile Platform for Cancer Imaging and Therapy
Volume: 25 Issue: 25
关键词: 纳米无机物,BSA,药物载体,表面修饰,生物模拟纳米粒子,癌症成像和治疗。
摘要: Background: Due to the good biocompatibility, biodegradability, facile surface functionalization and high water solubility, Bovine serum albumin has gain increasing attention in the nanomedicine.
Objective: Despite there are many reviews on albumin based nanoparticles, most of them focus on one aspect of the albumin functionality, e.g., drug delivery, cancer theranostics or half-life extension in vivo. This review aims to comprehensively summary bovine serum albumin as a versatile platform in the applications of cancer imaging and therapy.
Methods: We review the extensive applications of bovine serum albumin in drug carrier, surface engineering and biomimetic synthesis for cancer imaging and therapy.
Conclusion: Based on the studies reviewed, variety of in vitro and in vivo studies show good performance of bovine serum albumin as the drug carrier, surface modification agent and biomimetic template in cancer imaging and therapy. Nevertheless, there are still some issues to be solved, e.g., the technological parameters for enhancing the drug loading efficiency and controlling drug release, optimizing surface modification process to provide more stable nanoagents, investigation of the biomimetic mechanism, in-depth study of their toxicity, further exploring their bioapplications, etc.
Export Options
About this article
Cite this article as:
Bovine Serum Albumin as a Versatile Platform for Cancer Imaging and Therapy, Current Medicinal Chemistry 2018; 25 (25) . https://dx.doi.org/10.2174/0929867324666170314143335
DOI https://dx.doi.org/10.2174/0929867324666170314143335 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements